Table I.
Characteristics of patients with palliative care for MBO due to gynecological malignancy (n=53).
| Characteristic | Value |
|---|---|
| Age, median (range), years | 58 (35–85) |
| Origin of primary disease, n (%) | |
| Cervix | 9 (17) |
| Corpus | 11 (21) |
| Ovary | 29 (55) |
| Fallopian tube | 1 (2) |
| Primary peritoneal | 3 (6) |
| ECOG performance status, n (%) | |
| 1 | 18 (34) |
| 2 | 23 (43) |
| 3 | 11 (21) |
| 4 | 1 (2) |
| History of anticancer therapya, n (%) | |
| Surgery | 49 (92) |
| Chemotherapy | 50 (94) |
| Radiotherapy | 17 (32) |
| Time from primary therapy to diagnosis of MBO, median (range), days | 780 (30–4486) |
| Treatment-free interval between last anticancer therapy and diagnosis of MBO, median (range), days | 51 (6–512) |
| Presence of massive ascites, n (%) | |
| Yes | 25 (47) |
| No | 28 (53) |
| Palliative procedure performed for MBO, n (%) | |
| Pharmacological treatment only | 33 (62) |
| Laparotomy | 20 (38) |
ECOG, Eastern Cooperative Oncology Group.
a
Includes more than one per patient.
MBO, malignant bowel obstruction.